Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093210
Status:
COMPLETED
Last Update Posted:
2007-12-05
First Post:
2004-10-04
Brief Title:
Study Evaluating of Recombinant Human Factor IX BeneFIX and a New Formulation of BeneFIX rFIX-R in Moderate to Severe Hemophilia B
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hemophilia B |
Keywords: